Detalhe da pesquisa
1.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331369
2.
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.
Liver Int
; 41(3): 598-607, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188713
3.
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.
Liver Int
; 39(12): 2214-2229, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31436873
4.
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.
Invest New Drugs
; 33(1): 169-76, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25318436
5.
High-spatial and high-temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved three-dimensional radial MRI.
Magn Reson Med
; 71(3): 934-41, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23519837
6.
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors.
Invest New Drugs
; 32(2): 323-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114123
7.
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer.
Invest New Drugs
; 32(2): 295-302, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23860642
8.
Quantitative hepatic perfusion modeling using DCE-MRI with sequential breathholds.
J Magn Reson Imaging
; 39(4): 853-65, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24395144
9.
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.
Lancet Oncol
; 14(9): 882-92, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23810788
10.
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
Invest New Drugs
; 31(4): 943-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23263993
11.
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies.
Invest New Drugs
; 31(6): 1539-46, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114121
12.
A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.
Oncologist
; 16(6): 835-43, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21632454
13.
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
Oncologist
; 16(4): 452-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21393344
14.
A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer.
Invest New Drugs
; 29(1): 118-25, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19763400
15.
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States.
Pragmat Obs Res
; 11: 27-43, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32431558
16.
Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.
J Inorg Biochem
; 102(4): 693-8, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18061679
17.
Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.
Anticancer Res
; 36(3): 845-52, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976970
18.
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.
J Clin Oncol
; 33(13): 1475-81, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512461
19.
Glutamate mediates cell death and increases the Bax to Bcl-2 ratio in a differentiated neuronal cell line.
Brain Res Mol Brain Res
; 128(2): 160-9, 2004 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-15363891
20.
Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
Brain Res Mol Brain Res
; 128(1): 20-9, 2004 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15337314